Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P138. Clinical remission in ulcerative colitis one year after diagnosis is an unreliable terminology
P138. Infliximab modulates IL23–IL17 axis in patients with inflammatory bowel diseases
P138. The prevalence of vitamin D deficiency in adult patients with Crohn's disease on anti-TNF alpha therapy: report from a large UK teaching hospital
Authors:

H. Woodland1, E. Arthurs1, A. Fraser1, J. Tyrrell-Price1, T. Creed1, 1University Hospital Bristol, Gastroenterology, Bristol, United Kingdom

P138

Health Quality and Sexual Dysfunction in Turkish IBD Patients

Authors:

M. Törüner*1, E. Ates2, C. Kalkan1, F. Karakaya1, H. Cetinkaya1, I. Soykan1

1Ankara University School of Medicine, Dept. Gastroenterology, Ankara, Turkey, 2Ankara University School of Medicine, Dept. Internal Medicine, Ankara, Turkey

P139.

Serum hepcidin levels predict intestinal iron absorption in IBD patients

Authors:

M. Wiesenthal1, A. Dignass2, F. Hartmann1, T. Iqbal3, J. Stein1, 1Crohn Colitis Center, DGD Krankenhaus Sachsenhausen, Frankfurt, Germany, 2Agaplesion Markus Hospital, Department of Medicine I, Frankfurt, Germany, 3Gastroenterology Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom

P139. Asymptomatic brain lesions on cranial magnetic resonance imaging in inflammatory bowel disease
P139. Different scoring methods affect the accuracy of clinical outcomes in ulcerative colitis. Post-hoc analysis in a phase 2a study with interferon-β-1a
P139. The learning curve of intestinal ultrasonography in assessing inflammatory bowel disease – preliminary results
Authors:

M. Monteleone1, A. Friedman2, F. Furfaro1, A. Dell'Era1, C. Bezzio1, G. Maconi1, 1Gastrointestinal Unit – L. Sacco university Hospital, Clinical Sciences, Milan, Italy, 2The Alfred Hospital and Monash University, Department of Gastroenterology, Melbourne, Australia

P139

Predictive Factors for Differentiating between Crohn's disease and Intestinal tuberculosis in Korea

Authors:

Y. Jung*1, K.C. Huh2, S.M. Yoon3, H.S. Koo2, H.D. Shin4, J.E. Shin4, H.S. Moon5, S.B. Kang6, J.R. Lee7, H. Young8

1Soonchunhyang University College of Medicine, Department of Internal Medicine, Cheonan-si, Korea, Republic of, 2Konyang University College of Medicine, Department of Internal Medicine, Daejeon, Korea, Republic of, 3Chungbuk National University College of Medicine, Internal Medicine, Cheongju, Korea, Republic of, 4Dankook University College of Medicine, Internal medicine, Cheonan, Korea, Republic of, 5Chungnam National University Hospital, Department of Internal Medicine, Daejeon, Korea, Department of Internal Medicine, Daejeon, Korea, Republic of, 6St. Mary's Hospital, College of Medicine, Department of Internal Medicine, Daejeon, Korea, Republic of, 7Konkuk University of Medicine, Department of Internal Medicine, Chungju, Korea, Republic of, 8Soonchunhyang University College of Medicine, Department of Preventive medicine, Cheonan-si, Korea, Republic of

P140.

Serum concentrations of insulin-like growth factor-binding protein 5 in Crohn's disease

Authors:

G. Adali, E. Yorulmaz, S. Ozkanli, C. Ulasoglu, B. Bayraktar, A. Orhun, Y. Colak, I. Tuncer, Goztepe Training and Research Hospital, Department of Gastroenterology, Istanbul, Turkey

P140. Anti-TNF therapy and pregnancy in inflammatory bowel disease: A prospective cohort study from the GETAID [GETAID]
P140. Sustained restoration of health related quality of life in Crohn's disease patients with adalimumab maintenance therapy
Authors:

F. Casellas1, V. Robles2, A. Torrejon2, E. Navarro2, E. Ruiz2, N. Borruel2, 1Hospital Universitari Vall d'Hebron. Ciberehd., Barcelona, Spain, 2Hospital Universitari Vall d'Hebron, Spain

P140. The relation between resistin and insulin resistance in inflammatory bowel disease patients
P140

Proximity Extension Assay technology identifies novel serum biomarkers for predicting Inflammatory Bowel Disease: IBD Character Consortium

Authors:

R. Kalla*1, N. Kennedy1, F. Hjelm2, E. Modig2, M. Sundell2, B. Andreassen3, D. Bergemalm4, P. Ricanek5, J. Söderholm6, M. Vatn3, J. Halfvarson4, M. Gullberg2, - IBD Character Consortium7, J. Satsangi1

1University of Edinburgh, Gastrointestinal unit, Edinburgh, United Kingdom, 2Olink , Bioscience, Uppsala, Sweden, 3University of Oslo, Institute of Clinical Medicine, Oslo, Norway, 4Örebro University, Department of Gastroenterology, Örebro, Sweden, 5Akershus University Hospital, Department of Gastroenterology, Lørenskog, Norway, 6Linköping University, Gastroenterology, Linköping, Sweden, 7European IBD Character consortium, FP7, Edinburgh, United Kingdom

P141.

Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn's disease activity

Authors:

A. Schoepfer1, T. Schaffer2, F. Seibold3, 1Centre Hospitalier Universitaire Vaudois, Gastroenterology, Lausanne, Switzerland, 2University of Bern, Department of Clinical Research, Bern, Switzerland, 3University Hospital Bern, Gastroenterology and Hepatology, Bern, Switzerland

P141. Cost effectiveness of standardised ferric carboxymaltose treatment versus individually calculated iron sucrose treatment for IBD-associated iron deficiency anaemia
P141. Mucosal cytokine profiles in early, untreated Crohn's disease
P141. Surgery during first 10 years of inflammatory bowel disease; our clinical experience
Authors:

G. Can1, A. Tezel1, H.C. Ümit1, A. Üstündag1, G. Dökmeci1, A.R. Soylu1, 1Trakya University Hospital, Gastroenterology Department, Edirne, Turkey

P141

Presence of anaemia is an indicator of long-term disease course in Inflammatory Bowel Diseases. Results from a population-based inception cohort

Authors:

P. Lakatos*1, P.A. Golovics1, Z. Vegh1, B. Lovasz1, I. Szita2, M. Balogh3, S. Vavricka4, G. Rogler4, L. Lakatos2

1Semmelweis University, 1st Department of Medicine, Budapest, Hungary, 2Csolnoky F. Province Hospital, Department of Medicine, Veszprem, Hungary, 3Grof Eszterhazy Hospital, Department of Medicine, Papa, Hungary, 4University Hospital Zurich, Department of Internal Medicine, Division of Gastroenterology and Hepatology, Zurich, Switzerland

P142.

Sensitivity of Lennard-Jones criteria in the diagnosis of Crohn's disease

Authors:

S. Reinisch1,2, K. Schweiger3, B. Collet-Fenetrier4, L. Peyrin-Biroulet4, J. Panés5, W. Reinisch2,6, 1McMaster University, Internal Medicine, Hamilton, Canada, 2Medical University of Vienna, Internal Medicine, Vienna, Austria, 3Wilhelminenspital, Internal Medicine, Vienna, Austria, 4University and Hospital, Gastroenterology, Nancy, France, 5Hospital Clinic Barcelona, Gastroenterology Service, Barcelona, Spain, 6McMaster University, Internal Medicine, Hamilton, Canada